Inventor · disambiguated record
Florian Paul Christian Binder
Also filed as: BINDER FLORIAN · BINDER FLORIAN PAUL CHRISTIAN
23 granted patents·17 pending applications·129 citations·filing 1989–2024
95Inventor score
Files withBOEHRINGER INGELHEIM INT31CENTREXION THERAPEUTICS CORP6ANDERSKEWITZ RALF1CONSORTIUM ELEKTROCHEM IND1RIETHER DORIS1
Top patents by PatentIndex Score
40 records- 0196US9713606B2Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin CBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jul 25, 2017·20 cites·25 claims
- 0296US8987249B2Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin CANDERSKEWITZ RALF·Filed 2014·Granted Mar 24, 2015·48 cites·26 claims
- 0395US10238633B2Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin CBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 26, 2019·18 cites·25 claims
- 0493US11661427B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted May 30, 2023·3 cites·32 claims
- 0593US11578080B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 14, 2023·2 cites·33 claims
- 0691US11725004B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 15, 2023·1 cites·16 claims
- 0791US11084810B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·2 cites·18 claims
- 0890US11884681B23H,4H,5H,6H,7H-pyrimido[4,5-b][1,4]oxazine-4,6-dione derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 30, 2024·1 cites·9 claims
- 0990US11136336B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 5, 2021·2 cites·12 claims
- 1089US11858921B2Uracil derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 2, 2024·1 cites·9 claims
- 1189US11661430B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted May 30, 2023·3 cites·29 claims
- 1289US10570125B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Feb 25, 2020·4 cites·20 claims
- 1388US10112934B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Oct 30, 2018·4 cites·25 claims
- 1487US11891403B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 6, 2024·1 cites·34 claims
- 1586US12344601B2(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 1686US8865744B1(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesRIETHER DORIS·Filed 2014·Granted Oct 21, 2014·8 cites·5 claims
- 1786US2023310373A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1884US9650370B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2014·Granted May 16, 2017·5 cites·32 claims
- 1979US2020138780A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2077US2021260027A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2177US2024352032A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2274US2025092019A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2374US2024352033A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2470US2023257395A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2568US2019167636A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2668US2025059165A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2768US2025059166A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2868US2025066329A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2967US2024317712A1Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3066US11884652B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Jan 30, 2024·0 cites·34 claims
- 3166US2015105375A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2014·Application pending·0 cites
- 3266US2024246981A1Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3365US12180223B23H,4H-thieno[2,3-d]pyrimidin-4-one derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Dec 31, 2024·0 cites·9 claims
- 3465US11878981B2Substituted 1,2,4-oxadiazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 23, 2024·0 cites·13 claims
- 3565US2024059675A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3662US12497401B2Substituted tetrazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Dec 16, 2025·0 cites·7 claims
- 3762US10941137B2Difluoromethyl-phenyl triazolesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 9, 2021·0 cites·3 claims
- 3859US2021107919A1Novel ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3957US2021147393A1Difluoromethyl-phenyl triazolesBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4044US5395927ADNA-fragment having the cyclodextrin glycosyltranferase geneCONSORTIUM ELEKTROCHEM IND·Filed 1989·Granted Mar 7, 1995·6 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Florian Paul Christian Binder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →